Diagnostic methods for determining prognosis of non-small cell lung cancer
US9291625B2 · kind B2 · utility
1Cited by
8References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 25, 2010 |
| Grant date | Mar 22, 2016 |
| Priority date | — |
| Expiry date | Oct 25, 2030 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/60
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present disclosure provides methods for identifying early stage non-small-cell lung cancer (NSCLC) patients who will have an unfavorable prognosis for the recurrence of lung cancer after surgical resection. The methods are based in part on the discovery of chromosomal copy number abnormalities that can be used for prognostic classification. The methods preferably use fluorescence in situ hybridization with fluorescently labeled nucleic acid probes to hybridize to patient samples to quantify the chromosomal copy number of these genetic loci.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.